About this trial
Radicle Performance™ VKN: A randomized, double-blind, placebo controlled direct-to-consumer study assessing the impact of health and wellness products on fatigue and related health outcomes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults, aged 35-60 at the time of electronic consent, inclusive of all ethnicities, races, and gender identities
Assigned sex at birth will determine sex-specific recruitment and PROs (male vs female) employed, when needed
Experiencing fatigue and/or perceiving a decline in sports performance due to tiredness
Resides in the United States
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Placebo Health Performance Control
Dietary supplementParticipants will use their Placebo Health Performance Control as directed for a period of 4 weeks
Active Health Performance Product
Dietary supplementParticipants will use their Active Health Performance Product as directed for a period of 4 weeks
Treatment groups
Trial outcomes
Primary outcomes
Change in fatigue
Fatigue score as assessed by Patient Reported Outcome Measurement System (PROMIS) Fatigue 8A (scale 8-40; where higher scores correspond to more severe fatigue)
Secondary outcomes
Change in sleep
Sleep score as assessed by PROMIS Sleep Disturbance 8A (scale 8-40; where higher scores correspond to higher levels of sleep disturbance)
Change in feelings of stress
Stress score as assessed Perceived Stress Scale 4 (PSS-4) (scale 0-16; where lower scores correspond to less stress)
Other outcomes
Minimal clinically important difference (MCID) in fatigue
Minimal clinically important difference (MCID) in fatigue: Likelihood of experiencing minimal clinically important difference in fatigue score as assessed by PROMIS Fatigue 8A (scale 8-40; where higher scores correspond to more severe fatigue)
Minimal clinically important difference (MCID) in sleep
Minimal clinically important difference (MCID) in sleep: Likelihood of experiencing minimal clinically important difference in sleep score as assessed by PROMIS Sleep Disturbance 8A (scale 8-40; where higher scores correspond to higher levels of sleep disturbance)
Minimal clinically important difference (MCID) in feelings of stress
Minimal clinically important difference (MCID) in feelings of stress: Likelihood of experiencing minimal clinically important difference in feelings of stress as assessed by Perceived Stress Scale (PSS-4) (scale 0-16; where lower scores correspond to less stress)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: